IAEA scientific and technical publications can be searched by multiple parameters: year of publication, topic and type. Use the facets to input your search criteria or the text field to search by ...

Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...

Ho Chi Minh City is currently facing a critical shortage of radiopharmaceuticals needed for PET/CT scans, crucial in ...

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Biotechnology stocks also gained. Although merger and acquisition (M&A) activity slowed, deals continued in growth areas such as radiopharmaceuticals, including Novartis' (NVS) acquisition of Mariana ...

Due to advances in prevention, early detection and treatment, the overall cancer death rate in the U.S. fell by 33% between ...

These ASX healthcare stocks are ending the week strongly. Why are investors snapping up their shares on Friday?

Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor conferences in New York City. ITM's Chief ...

Oxford Engineering, led by Chairman Karim Sekkat, is a leading integrated manufacturing solutions company that applies ...

Search by Title, ISBN, ISSN, Series Info Number (-) Remove Diagnostic radiopharmaceuticals filter Diagnostic radiopharmaceuticals Department of Nuclear Sciences and Applications (2) Apply Department ...